Literature DB >> 10212111

Collagen degrading activity associated with Mycobacterium species.

F Massó1, A Paéz, E Varela, L D de León, E Zenteno, L F Montaño.   

Abstract

BACKGROUND: The mechanism of Mycobacterium tuberculosis penetration into tissues is poorly understood but it is reasonable to assume that there is a contribution from proteases capable of disrupting the extracellular matrix of the pulmonary epithelium and the blood vessels. A study was undertaken to identify and characterise collagen degrading activity of M tuberculosis.
METHODS: Culture filtrate protein extract (CFPE) was obtained from reference mycobacterial strains and mycobacteria isolated from patients with tuberculosis. The collagen degrading activity of CFPE was determined according to the method of Johnson-Wint using 3H-type I collagen. The enzyme was identified by the Birkedal-Hansen and Taylor method and its molecular mass determined by SDS-PAGE and Sephacryl S-300 gel filtration chromatography using an electroelution purified enzyme.
RESULTS: CFPE from Mycobacterium tuberculosis strain H37Rv showed collagenolytic activity that was four times higher than that of the avirulent strain H37Ra. The 75 kDa enzyme responsible was divalent cation dependent. Other mycobacterial species and those isolated from patients with tuberculosis also had collagen degrading activity.
CONCLUSIONS: Mycobacterium species possess a metalloprotease with collagen degrading activity. The highest enzymatic activity was found in the virulent reference strain H37Rv.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212111      PMCID: PMC1763775          DOI: 10.1136/thx.54.5.439

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure.

Authors:  M Riley; D B Northridge; E Henderson; C F Stanford; D P Nicholls; H J Dargie
Journal:  Eur Heart J       Date:  1992-10       Impact factor: 29.983

Review 2.  Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease.

Authors:  D J Harrington
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases.

Authors:  J C Chang; A Wysocki; K M Tchou-Wong; N Moskowitz; Y Zhang; W N Rom
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

4.  Multiple factors limit exercise capacity in cystic fibrosis.

Authors:  J E Marcotte; R K Grisdale; H Levison; A L Coates; G J Canny
Journal:  Pediatr Pulmonol       Date:  1986 Sep-Oct

Review 5.  Exercise and cystic fibrosis.

Authors:  A K Webb; M E Dodd; J Moorcroft
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

6.  Entamoeba histolytica: electron-dense granule secretion, collagenase activity and virulence are altered in the cytoskeleton mutant BG-3.

Authors:  J J Serrano; M de la Garza; M A Moreno; R Tovar; G León; V Tsutsumi; M L Muñoz
Journal:  Mol Microbiol       Date:  1994-02       Impact factor: 3.501

7.  Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation.

Authors:  S J Singh; M D Morgan; A E Hardman; C Rowe; P A Bardsley
Journal:  Eur Respir J       Date:  1994-11       Impact factor: 16.671

8.  Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.

Authors:  M C Bruce; L Poncz; J D Klinger; R C Stern; J F Tomashefski; D G Dearborn
Journal:  Am Rev Respir Dis       Date:  1985-09

9.  The involvement of collagenase in the necrosis induced by the bites of some spiders.

Authors:  R K Atkinson; L G Wright
Journal:  Comp Biochem Physiol C       Date:  1992-05

10.  Development of a shuttle walking test of disability in patients with chronic airways obstruction.

Authors:  S J Singh; M D Morgan; S Scott; D Walters; A E Hardman
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.